Growth momentum West Pharmaceutical Services is a large, multinational supplier with significant recent revenue growth in 2025 and 2026, signaling expanding demand for injectable containment and delivery components that sales teams can target with expanded product and service bundles.

Proprietary products strength The Proprietary Products segment generated the vast majority of recent revenue, with strong year-over-year gains, presenting an opportunity to upsell advanced primary containment, silicone-free containers, and packaging innovations to elevate patient safety and regulatory compliance.

Cyber security needs Industry-wide cyber incidents highlight potential demand for enhanced digital solutions, data integrity, and secure enterprise platforms; there is a cross-sell opportunity to offer secure manufacturing IT, data protection, and supply-chain visibility tools aligned with their ongoing digital transformation.

Executive turnover Recent leadership changes and talent movements in digital, transformation, and commercial strategy roles suggest timing-sensitive engagement for strategic partnerships, consulting services, and co-developed solutions to support continuity and accelerated go-to-market initiatives.

Global scale With 50 sites worldwide and billions of components shipped annually, West is positioned for global sourcing, standardized process improvements, and regional manufacturing optimization opportunities that can be paired with compliant, scalable packaging, labeling, and sterilization technologies.